The employees gathered with latent anxiety, feigning a sense of confidence and gratitude for their leader's visit. Standing in their midst, he slowly, yet with an air of faux regal aplomb, delivered his message... muttering something about waiting for Godot.
Intarcia Therapeutics
- Thread starter anonymous
- Start date
-
- Tags
- None
The employees gathered with latent anxiety, feigning a sense of confidence and gratitude for their leader's visit. Standing in their midst, he slowly, yet with an air of faux regal aplomb, delivered his message... muttering something about waiting for Godot.
Sounds like Intracia's grand disruption plans are totally derailed and DISRUPTED. LOL Couldn't happen to 1 fxcked up company whose sorry ass egos got on the way and couldn't even hire the reps. JS was such a tool and arrogant as hell ahole protected by KG soon to be called the slasher slayer in truly fxcked up factory in Hayward to trim the ranks.
You deserve it all mother fxckers!
You deserve it all mother fxckers!
gettin drunk at lunch on saturday. damn girlfriend all up in my stuff about wantin vacation. cant do sumtin when imma on the chopping block. gotta get a better spot before this really stinks. hey how bout posting like links to real jobs or sumtin. Indeed has a Berkeley Lights job - anyone heard about it ?
What happend to the other generic exenatide implants are they now in the lead since Intarica blew up ?
-Delpor’s titanium drug-eluting device that delivers exenatide for treatment of type II diabetes. Delpor’s system also is designed to deliver drugs for treating bipolar disorder, growth hormone deficiencies, and hepatitis C.
-NanoPrecision Medical is developing NanoPortalTM, a rice-size titanium implant that delivers exenatide for type II diabetes.
What happened to the once a year story ? where did it go ?
Intarcia’s technology, ITCA 650, is a DUROS® implant delivery technology licensed from the ALZA Corporation in 2007. ITCA 650 is a small, matchstick-sized osmotic pump consisting of a cylindrical titanium alloy reservoir that is implanted subcutaneously and delivers a steady flow of exenatide, a glucagon-like peptide-1 receptor agonist, for 12 months.
What happent to the first DUROS product to be approved ? Why is this now a big idea ?
Viadur, which received marketing approval from the U.S. Food and Drug Administration in March 2000, is the first and only product to provide continuous, 12-month testosterone suppression with a single treatment, and is the first approved product to incorporate ALZA 's proprietary DUROS implant technology.
-Delpor’s titanium drug-eluting device that delivers exenatide for treatment of type II diabetes. Delpor’s system also is designed to deliver drugs for treating bipolar disorder, growth hormone deficiencies, and hepatitis C.
-NanoPrecision Medical is developing NanoPortalTM, a rice-size titanium implant that delivers exenatide for type II diabetes.
What happened to the once a year story ? where did it go ?
Intarcia’s technology, ITCA 650, is a DUROS® implant delivery technology licensed from the ALZA Corporation in 2007. ITCA 650 is a small, matchstick-sized osmotic pump consisting of a cylindrical titanium alloy reservoir that is implanted subcutaneously and delivers a steady flow of exenatide, a glucagon-like peptide-1 receptor agonist, for 12 months.
What happent to the first DUROS product to be approved ? Why is this now a big idea ?
Viadur, which received marketing approval from the U.S. Food and Drug Administration in March 2000, is the first and only product to provide continuous, 12-month testosterone suppression with a single treatment, and is the first approved product to incorporate ALZA 's proprietary DUROS implant technology.
I checked. They’re not hiring anyone with experience in making implausible devices. I guess I’ll just have to go on unemployment.
Try Buffalo Wild Wings in Hayweird. Maybe you will get better tips from the dirtbags still hanging on to hopes in Industrial Blvd.
No not going to happen as king of the hill KG said Intarcia has the sterling IP portfolio which prevents others from joining the fray.
Teva is also working on generic Victoza in addition to generic Byetta. Payer will demand lower prices across the board from the rest of GLP-1 purveyors and real squeeze to the most expensive GLP drug ITCA that is IF it ever gets approved.
Anyone know how much cash and cash equivalent Intarcia has access to now?
Anyone know how much cash and cash equivalent Intarcia has access to now?
Anyone know how much cash and cash equivalent Intarcia has access to now?[/QUOTE]
Good question as army of incompetent comms,design,sales,and CX buffoons still on board drawing fat salaries.
Good question as army of incompetent comms,design,sales,and CX buffoons still on board drawing fat salaries.
the securities regulator also delivered a thinly veiled warning that private firms raising billions on the promise of disruption will be held to account
Jina Choi director SEC “Innovators who seek to revolutionize and disrupt an industry must tell investors the truth about what their technology can do today, not just what they hope it might do someday”
What was that... Intarcia will have once a year “eventually” ??
What happened to the disruptive once a year pump ? Pump Boi in trouble !
Jina Choi director SEC “Innovators who seek to revolutionize and disrupt an industry must tell investors the truth about what their technology can do today, not just what they hope it might do someday”
What was that... Intarcia will have once a year “eventually” ??
What happened to the disruptive once a year pump ? Pump Boi in trouble !
Good question as army of incompetent comms,design,sales,and CX buffoons still on board drawing fat salaries.[/QUOTE]
Not for long as Boston HQ really needs deep gutting as ITCA ain't going to approved anytime soon with its device woes that will take some time to fix, possibly long bridging study and resubmit with fingers crossed for approval. IMHO - best case mid 2019.
You know nothing. We are worth $ 5.5 Billion and are on target for IPO in 2019 - a year ago $3.72 Billion
Intarcia Therapeutics
$3.72B Dec 2016 +200%
Venrock (Series D)
GGV Capital (Series E)
New Leaf Venture Partners (Series B)
RA Capital Management (Series D)
Baillie Gifford (Series E)
Bill & Melinda Gates Foundation (Series E)
USA Healthcare
Here are partial list on bagholders. Folly in investment worth few cents to dollar by end of 2018 - mark my words.
Oldie but goodie fro late Oct 2017 - was this fake news or is DoJ still fishing for promotional materials used in fund raising?
Not for long as Boston HQ really needs deep gutting as ITCA ain't going to approved anytime soon with its device woes that will take some time to fix, possibly long bridging study and resubmit with fingers crossed for approval. IMHO - best case mid 2019.[/QUOTE]
You sir are an idiot. You don’t know it, but you have no idea of reality. No way best case mid 2019. Much much longer than that. Actually will never happen. All those that think this shxt hole company will ever come to fruition are supreme mega idiots.